Nimble. Transparent. Scientifically Grounded.
Your Pharmacology and Early Clinical Research Partner
We aren’t just a CRO, we’re a part of your team working to get your drug to market safely, efficiently and following all regulations for clinical research execution. We conduct studies in healthy volunteers and targeted populations.
Explore Our Comprehensive Clinical Solutions
What Our Sponsors Are Saying
"
Working with AXIS has been a game-changer for us. Their teams truly understand the unique challenges of conducting complex pharmacology cardiac safety TQT projects and have been incredibly responsive and proactive throughout the process. They’ve made what could have been a stressful journey much smoother, keeping timelines on track (exceeding expectations with seamless clinical and bioanalysis within same building and delivering high-quality data results. I highly recommend them as a partner.
Working with AXIS has been a game-changer for us. Their teams truly understand the unique challenges of conducting complex pharmacology cardiac safety TQT projects and have been incredibly responsive and proactive throughout the process. They’ve made what could have been a stressful journey much smoother, keeping timelines on track (exceeding expectations with seamless clinical and bioanalysis within same building and delivering high-quality data results. I highly recommend them as a partner.
Early Clinical Head, Specialty PharmaNew York
"
AXIS has been our long-time reliable partner for clinical research. Their team understands the challenges of developing 505(b)(2) products and has provided solid support throughout our clinical development program of studies. They’ve helped us stay on track and navigate a complex process with professionalism and quality data. I would recommend them to all of my industry contacts looking for a dependable CRO partner.
AXIS has been our long-time reliable partner for clinical research. Their team understands the challenges of developing 505(b)(2) products and has provided solid support throughout our clinical development program of studies. They’ve helped us stay on track and navigate a complex process with professionalism and quality data. I would recommend them to all of my industry contacts looking for a dependable CRO partner.
VP of R&D, 505b2 drug development companyWashington DC
"
AXIS has consistently delivered outstanding support as a Phase 1 site partner. Their ability to recruit and enroll subjects quickly and efficiently has been a key factor in keeping our timelines on track. The team is professional, responsive, and well-organized, ensuring the smooth execution of even the most complex pharmacology studies. We value their expertise and look forward to continued collaboration.
AXIS has consistently delivered outstanding support as a Phase 1 site partner. Their ability to recruit and enroll subjects quickly and efficiently has been a key factor in keeping our timelines on track. The team is professional, responsive, and well-organized, ensuring the smooth execution of even the most complex pharmacology studies. We value their expertise and look forward to continued collaboration.
Pharmaceutical, Senior Director, Head of Global Clinical Operations Japan
"
We've worked with AXIS Clinicals USA on several Phase 1 studies, and their ability to quickly enroll subjects has been a huge advantage for us. They’re efficient, easy to work with, and always meet our timelines. Their team handles everything smoothly, which makes our job easier. We’re grateful for their support and look forward to working with them again.
We've worked with AXIS Clinicals USA on several Phase 1 studies, and their ability to quickly enroll subjects has been a huge advantage for us. They’re efficient, easy to work with, and always meet our timelines. Their team handles everything smoothly, which makes our job easier. We’re grateful for their support and look forward to working with them again.
Sr. Director, Early Phase DevelopmentTop 5 CRO
Scroll to see more
We are trusted by more than 100 Biotech, 505(b)(2) and Pharmaceutical companies located across the globe.
AXIS News &
Case Studies
AXIS Clinicals US Expands Capabilities to Conduct hADME Studies for NDA Filings
DILWORTH, Minn., Dec. 20, 2024—AXIS Clinicals US is pleased to announce the award of a Radioactive Materials License (RAM License) issued from the Minnesota Department
Clinical Partnership Announcement
AXIS Clinicals LLC and Joanneum Research Forschungsgesellschaft mbH are excited to announce the first ever partnership for the clinical applications of dermal open flow microperfusion
AXIS Clinicals, a Clinical Research Organization, welcomes Dr. Keith Gallicano as a consultant as the Senior Advisor in Clinical & Scientific Affairs.
DILWORTH, MN, 1st March, 2021 – AXIS Clinicals added another member as part of the consultation team with the welcoming of Dr. Keith Gallicano as the Senior
AXIS Continues Clinical Research During COVID-19 Restrictions
Dilworth, MN – Clinical and bioanalytical studies supporting pharmacology projects and multi-site patient trials continue at AXIS. Various projects supporting research to address the Coronavirus